A Director at Hemispherx Biopharma Inc (HEB) is Buying Shares


Today, a Director at Hemispherx Biopharma Inc (HEB), William M. Mitchell, bought shares of HEB for $39K.

Following this transaction William M. Mitchell’s holding in the company was increased by 86.7% to a total of $86.69K. In addition to William M. Mitchell, one other HEB executive reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Currently, Hemispherx Biopharma Inc has an average volume of 129.1K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Hemispherx Biopharma, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts